The Sarah Cannon Transplant & Cellular Therapy Network offers patients convenient, community-based access to complex blood cancer care, hematopoietic cell transplant (HCT) (sometimes called blood and marrow transplant), clinical trials, and innovative therapies such as immune effector cell therapy (IECT). The Network also provides care for those facing blood disorders and other immune-related disorders.
Sarah Cannon is one of the world’s largest providers of hematopoietic cell transplant (HCT), treating approximately 1,600 transplant and cellular therapy patients per year. In fact, data shows the Sarah Cannon Transplant & Cellular Therapy Network, with 9 FACT/JACIE-accredited programs, is the largest provider of HCT's in the United States, tracking ahead of all major academic medical centers and networks.
Austin
The Sarah Cannon Transplant & Cellular Therapy Program at St. David’s Medical Center is a FACT accredited HCT program that performs autologous and allogeneic transplants for hematologic malignancies. The transplant and cellular therapy program was established at Methodist Hospital in 1993 and expanded to St. David’s South Austin Medical Center in 2014 to establish a comprehensive adult transplant program in Austin. The two sites operate together as one program by sharing common quality management processes, policies, procedures, physicians, nurse competencies and personnel.
Transplant types: Adult Autologous and Allogeneic Transplants - Related/Unrelated/Haploidentical
Dallas
Medical City’s Stem Cell Transplantation and Research Program, founded in 1994, performs both adult and pediatric stem cell transplants, including autologous and allogeneic. From clinical workup to transplantation, each facet of the stem cell program is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT).
Transplant types: Adult and Pediatric Autologous, Allogeneic - Related/Unrelated/Haploidentical/UCB
Denver
Colorado Blood Cancer Institute (CBCI), a part of the Sarah Cannon Cancer Institute at Presbyterian/St. Luke’s Medical Center, is the largest and most experienced blood and marrow transplant (BMT) program in Colorado, and is among the top programs in the country. The program is accredited by the Foundation for the Accreditation of Cellular Therapies (FACT), which is the global standard for top quality patient care in cellular therapy. Colorado Blood Cancer Institute (CBCI) Blood and Marrow Transplant Program is the region’s largest transplant program, and has been continuously recognized as a leader in patient care and outcomes. The program cares for patients throughout the whole spectrum of hematologic malignancy and has many active clinical trials.
Transplant types: Adult Autologous, Allogeneic - Related/Unrelated/Haploidential/UCB
Learn more about Colorado Blood Cancer Institute.
Kansas City
The Sarah Cannon Transplant & Cellular Therapy Program at Research Medical Center provides specialized care for patients with complex blood cancers. The program provides blood and marrow transplant, comprehensive outpatient services and a dedicated inpatient oncology unit supported by a multidisciplinary team of specialists. Sarah Cannon Transplant & Cellular Therapy Program at Research Medical Center began its adult autologous blood and marrow transplant services in 2019 and is FACT accredited.
Transplant types: Adult Autologous
Las Vegas
The Sarah Cannon Transplant & Cellular Therapy Program at MountainView Hospital is the only program in Nevada that offers autologous transplant for patients with blood cancers and other disorders. This means Nevadans don't have to leave the state to receive lifesaving care.
The program offers comprehensive, compassionate and personalized care in a supportive environment for patients with blood cancers such as leukemia, lymphoma and multiple myeloma. The program offers a highly specialized team approach to care for our patients, with a dedicated nurse coordinator who monitors each transplant patient and creates personalized treatment plans.
Transplant Types: Adult Autologous
Nashville
The mission of the Sarah Cannon Cancer Transplant & Cellular Therapy Program at TriStar Centennial is to ensure access for patients with hematologic malignancies to compassionate, state-of-the-art care and clinically meaningful innovative therapies. The multidisciplinary team offers comprehensive management of newly diagnosed, relapsed, refractory, acute or chronic malignancies, through personalized treatment plans including standard of care and clinical trials. The adult program was established in 2007 and is a Foundation for the Accreditation on Cellular Therapy (FACT)-accredited facility for autologous and allogeneic blood and marrow transplantation. In addition to offering standard-of-care transplant services, we also offer FDA-approved CAR T-Cell Therapy. The Sarah Cannon Pediatric Transplant & Cellular Therapy Program at TriStar Centennial began seeing pediatric transplant patients in 2015.
Transplant types: Adult and Pediatric Autologous, Allogeneic - Related/Unrelated/Haploidentical
San Antonio
The adult Sarah Cannon Transplant & Cellular Therapy Program at Methodist Hospital was established in 1993 and has the distinction of being the first in North America to be accredited by the Foundation for the Accreditation on Cellular Therapy (FACT) for both adult and pediatric stem cell transplants as well as CAR T-Cell Therapy. Methodist Hospital in partnership with Sarah Cannon Transplant & Cellular Therapy Network is able to offer patients access to a number of quality, infrastructure, training and research resources. The program consistently ranks among the nation’s top transplant centers in one-year patient survival rates and has an exceptional multidisciplinary team that specializes in every aspect of the transplant process and is available to support you through every stage starting with the initial consult all the way to long-term survivorship.
Transplant types: Adult and Pediatric Autologous, Allogeneic - Related/Unrelated/Haploidentical/UCB
Learn more about our adult blood cancer and stem cell program.
More information about our pediatric program..
United Kingdom
The adult Blood Cancer and Stem Cell Transplant Program in the UK was established in 2006 in partnership with prestigious teaching hospitals. We partner with University College Hospital London, Guys and St Thomas’ in London and The Christie in Manchester. Each of these locations has received the highest rating of Outstanding from England’s health regulator The Care Quality Commission (CQC), this rating reflects the highest standard of safe and effective care.
Transplant types: Adult Autologous and Allogeneic Transplants Related/Unrelated/Haploidentical/UCB
HCA Healthcare UK at University College Hospital London, Private Care (London)
The adult Blood Cancer and Stem Cell Transplant Program at HCA UK at UCH was established in 2006 in partnership with one of the UKs most prestigious teaching hospitals. The bone marrow and haematopoietic stem cell transplant service at University College Hospital is the largest transplant centre in Europe and provides a full range of transplant services. The private patient program achieved JACIE accreditation in 2009 and the highest rating of Outstanding from England’s health regulator The Care Quality Commission (CQC), this rating reflects the highest standard of safe and effective care.
Transplant types: Adult Autologous and Allogeneic Transplants Related/Unrelated/Haploidentical/UCB
The Christie Private Care, part of HCA Healthcare UK, in Manchester
HCA UK partnered with The Christie NHS Foundation Trust in 2010 to expand our UK blood network to Manchester in the North West of England, developing an adult Blood Cancer and Stem Cell Transplant Program. The Christie is one of Europe’s leading cancer centres recognised for its pioneering cancer research. The private patient program achieved JACIE accreditation in 2014 and the highest rating of Outstanding from England’s health regulator The Care Quality Commission (CQC), this rating reflects the highest standard of safe and effective care.
Transplant types: Adult Autologous and Allogeneic Transplants Related/Unrelated/Haploidentical/UCB
Private Care at Guy's at London Bridge Hospital (London)
In 2014 HCA UK partnered with Guy’s and St Thomas’ NHS Foundation Trust, which is co-located to our London Bridge Hospital campus. The adult stem cell transplant programme at this site currently focuses on autologous stem cell transplant for blood cancers and auto immune conditions. This program achieved JACIE accreditation in 2016 and as part of the London Bridge campus achieved the highest rating of Outstanding from England’s health regulator The Care Quality Commission (CQC). We are currently working with physicians to further develop this transplant programme, working towards allogeneic transplant services.
Transplant types: Adult Autologous
University Hospitals Birmingham, 2023
credit: Morley Von Sternberg
HCA Healthcare UK has partnered with University Hospitals Birmingham located in the centre of the West Midlands region of England. Construction is currently underway on a new hospital based on the Queen Elizabeth Hospital campus. Plans for the new hospital include the expansion of our blood network with a comprehensive adult bone marrow and stem cell transplant program.
